Global Perspectives in Gynecologic Malignancies

Expert perspectives and strategic insights on the latest therapeutic developments in gynecologic malignancies.

March 26 and 30, 2021

Faculty Chair

Robert Coleman, MD

University of Texas, MD Anderson Cancer Center, Houston, TX


John Chan, MD 
UCSF Helen Diller Family Comprehensive Cancer Center, CA, US

Christina Fotopoulou, MD, PhD 

Imperial College London Healthcare Trust, London, UK

Jonathan Ledermann, MD
UCL Cancer Institute, London, UK

Ursula Matulonis, MD
Dana-Farber Cancer Institute, MA, US

Bradley Monk, MD 
Biltmore Cancer Center, AZ, US

Kathleen Moore, MD
OU Health, OK, US

David O’Malley, MD 

The Ohio State University College of Medicine, OH, US

Leslie M. Randall, MD 
UCI Health, CA, US

Brian Slomovitz, MD
University of Miami Hospital, FL, US

Sample Report

Start discovering the insights

View Report


  • Early Stage Ovarian Cancer
  • First-Line Treatments and Maintenance Therapy for Advanced Ovarian Cancer
  • Treatment Strategies for Relapsed Ovarian Cancer
  • Current Treatment and Future Directions for Advanced Endometrial Cancer
  • Early Stage Cervical Cancer
  • Advanced Cervical Cancer: Current and Future Treatment

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.